The arginine and GHRP-2 tests as alternatives to the insulin tolerance test for the diagnosis of adult GH deficiency in Japanese patients: a comparison.

The arginine + GHRH test has been established as an alternative to the insulin tolerance test (ITT) for the diagnosis of adult GH deficiency (AGHD). However, the glucagon, arginine, and GH releasing peptide-2 (GHRP-2) test are recommended as alternatives in Japan. The objective of this study was to evaluate the arginine and GHRP-2 tests as alternatives to the ITT for the diagnosis of AGHD in a Japanese population. Three stimulation tests (ITT, arginine test, and GHRP-2 test) were conducted in 71 pre-operative adult patients with pituitary tumors (age, 18-65 years). The peak GH responses to each test were examined. The peak GH responses were significantly lower with the ARG test (median 4.43 μg/L) (p < 0.0001) than with the ITT (median 9.38 μg/L), and the peak GH responses with the GHRP-2 test (median 28.88 μg/L) were higher (p < 0.0001). However, among the AGHD patients, there was no significant difference between the peak GH responses to the ARG test and the ITT. The sensitivities and specificities of the ARG / GHRP-2 tests compared to the ITT for the diagnosis of severe AGHD (peak GH responses to ITT ≤ 1.8 μg/L) were 93.8% / 81.3% and 85.5% / 94.5%, respectively. The arginine and GHRP-2 stimulation tests are acceptable alternatives to the ITT for the diagnosis of AGHD in Japanese patients. The method and criterion for the diagnosis of AGHD should be reconsidered and adjusted to each population.

[1]  K. Chihara,et al.  Clinical characteristics of Japanese adults with growth hormone deficiency: a HypoCCS database study. , 2011, Endocrine journal.

[2]  A. Shimatsu,et al.  Is there an undiscovered neurocircuit for regulating GH secretion? -Pitfalls of GHRP-2 and ITT as GH provocative tests-. , 2010, Endocrine journal.

[3]  M. Vance,et al.  American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in growth hormone-deficient adults and transition patients - 2009 update: executive summary of recommendations. , 2009, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[4]  M. Vance,et al.  American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in growth hormone-deficient adults and transition patients - 2009 update. , 2009, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[5]  M. C. Savanelli,et al.  A reappraisal of diagnosing GH deficiency in adults: role of gender, age, waist circumference, and body mass index. , 2009, The Journal of clinical endocrinology and metabolism.

[6]  K. Flegal,et al.  Anthropometric reference data for children and adults: United States, 2003–2006. , 2008, National health statistics reports.

[7]  G. Beccuti,et al.  Diagnosis of adult GH deficiency , 2008, Pituitary.

[8]  K. Chihara,et al.  A simple diagnostic test using GH-releasing peptide-2 in adult GH deficiency. , 2007, European journal of endocrinology.

[9]  E. Arvat,et al.  Growth hormone-releasing hormone combined with arginine or growth hormone secretagogues for the diagnosis of growth hormone deficiency in adults , 2001, Endocrine.

[10]  K. Ho,et al.  Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II : a statement of the GH Research Society in association with the European Society for Pediatric , 2007 .

[11]  Hayato Uchida,et al.  Differences in the relationship between BMI and percentage body fat between Japanese and Australian-Caucasian young men , 2006, British Journal of Nutrition.

[12]  M. Vance,et al.  Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society Clinical Practice Guideline. , 2006, The Journal of clinical endocrinology and metabolism.

[13]  Christina Wang,et al.  Influence of body mass index and gender on growth hormone (GH) responses to GH-releasing hormone plus arginine and insulin tolerance tests. , 2005, The Journal of clinical endocrinology and metabolism.

[14]  Katsuhiko Ase,et al.  Pharmacological Characteristics of KP-102 (GHRP-2), a Potent Growth Hormone-Releasing Peptide , 2004, Arzneimittelforschung.

[15]  F. Casanueva,et al.  Comparison between insulin tolerance test, growth hormone (GH)-releasing hormone (GHRH), GHRH plus acipimox and GHRH plus GH-releasing peptide-6 for the diagnosis of adult GH deficiency in normal subjects, obese and hypopituitary patients. , 2003, European journal of endocrinology.

[16]  D. Cook,et al.  Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency. , 2002, The Journal of clinical endocrinology and metabolism.

[17]  K. Hanew,et al.  The role of endogenous GHRH in arginine-, insulin-, clonidine- and l-dopa-induced GH release in normal subjects. , 2002, European journal of endocrinology.

[18]  S. Grottoli,et al.  Comparisons among old and new provocative tests of GH secretion in 178 normal adults. , 2000, European journal of endocrinology.

[19]  E. Arvat,et al.  Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults. , 1998, The Journal of clinical endocrinology and metabolism.

[20]  E. Ghigo,et al.  Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. , 1998, The Journal of clinical endocrinology and metabolism.

[21]  Fisker,et al.  L‐Arginine and insulin‐tolerance tests in the diagnosis of adult growth hormone deficiency: influence of confounding factors , 1998, Clinical endocrinology.

[22]  A. Rahim,et al.  The assessment of growth hormone status in normal young adult males using a variety of provocative agents , 1996, Clinical endocrinology.

[23]  E. Ghigo,et al.  Interaction of free fatty acids and arginine on growth hormone secretion in man. , 1994, Metabolism: clinical and experimental.

[24]  E. Arvat,et al.  Arginine potentiates but does not restore the blunted growth hormone response to growth hormone-releasing hormone in obesity. , 1992, Metabolism: clinical and experimental.

[25]  F. Casanueva,et al.  Effect of central cholinergic neurotransmission enhancement by pyridostigmine on the growth hormone secretion elicited by clonidine, arginine, or hypoglycemia in normal and obese subjects. , 1990, The Journal of clinical endocrinology and metabolism.

[26]  J. Schopohl,et al.  Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion. , 1988, The Journal of clinical endocrinology and metabolism.

[27]  A. Schally,et al.  Free fatty acids block growth hormone (GH) releasing hormone-stimulated GH secretion in man directly at the pituitary. , 1987, The Journal of clinical endocrinology and metabolism.

[28]  N. Ling,et al.  The effect of free fatty acids on growth hormone (GH)-releasing hormone-mediated GH secretion in man. , 1985, The Journal of clinical endocrinology and metabolism.

[29]  R. Blizzard,et al.  A comparison of the effects of insulin hypoglycaemia and arginine infusion on release of human growth hormone. , 1967, Lancet.

[30]  J. Hammond,et al.  The arginine provocative test: an aid in the diagnosis of hyposomatotropism. , 1967, The Journal of clinical endocrinology and metabolism.